Feature | Cardiovascular Business | July 17, 2017

SCAI Highlights News from Medicare Trustees Report and 2018 Medicare Physician Fee Schedule

Hospital Outpatient Prospective Payment System proposed rules also released

SCAI comments on CMS payment schedule

July 17, 2017 — The Centers for Medicare and Medicaid Services (CMS) released the 2017 Medicare Trustees Report, the 2018 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment Systems (HOPPS) proposed rules. The Society for Cardiovascular Angiography and Interventions (SCAI) offered the following synopsis of these extensive documents and how the proposals impact on cardiology. 

The Medicare Trustees Report contained good news with an estimated depletion date of 2029 for the trust fund, one year later than last year’s report; believed to be a result of lower inpatient hospital utilization assumptions and lower-than-expected spending in 2016. Also, last year's report prediction that spending levels in 2017 would likely trigger the creation of a cost-cutting, Independent Payment Advisory Board (IPAB) to rein in costs has not come to fruition.

The 2018 MPFS proposed rule revealed an overall update to payments under the MPFS of less than one percent with a proposed $0.10 cent increase to the Medicare conversion factor, raising the conversion factor from $35.89 to $35.99. However, the proposed rule presents an estimated decrease in payments to cardiology of 2 percent for 2018. The estimated 2 percent reduction in cardiology reimbursement is a result of an estimated 1 percent reduction in malpractice values coupled with an estimated 1 percent reduction in practice expense values.

CMS also pushed back the start date for when providers will be required to consult clinical decision support (CDS) for advanced diagnostic imaging (i.e. cardiac CT, cardiac MRI and nuclear perfusion imaging) to 2019.

The 2018 HOPPS proposed rule reflects an anticipated overall impact of 2 percent payment increase to hospitals in 2018 for services paid under HOPPS. The HOPPS proposed rules also reveals CMS' desire to address increasing drug costs by paying separately payable, non pass-through drugs (other than vaccines) purchased at a discount through the 340B drug pricing program at the average sales price (ASP) minus 22.5 percent rather than current ASP plus 6 percent rate.

In addition to the 2018 MPFS and HOPPS proposed rules, CMS issued a Request for Information (RFI) for both, seeking feedback on positive solutions to better achieve transparency, flexibility, program simplification, and innovation. This will inform the discussion on future regulatory action related to outpatient services performed at hospitals and services performed at ambulatory surgical centers related to the MPFS and the HOPPS RFI. 

SCAI advocacy staff and leaders will be reviewing the Medicare Trustees report, the proposed payment rules, and the RFI requests in greater detail and will share pertinent findings and any concerns with members over the coming weeks. 

For more information: www.scai.org

Related Content

Videos | Cardiovascular Business | April 16, 2019
A discussion with Ruth Fisher, MBA, vice president of the...
Foreign-trained doctors now make up one-third of cardiologists in the United States and help make up for the U.S. overall shortage of physicians. Pictured here is co-author of this article Mandeep R. Mehra, MBBS, MSc, FRCP, who is an example of the contribution international physicians have made in the U.S. He is medical director of the Brigham and Women’s Hospital Heart and Vascular Center.

Foreign-trained doctors now make up one-third of cardiologists in the United States and help make up for the overall shortage of physicians. Pictured here is co-author of this article Mandeep R. Mehra, MBBS, MSc, FRCP, who is an example of the contribution international physicians have made in the U.S. He is medical director of the Brigham and Women’s Hospital Heart and Vascular Center, The William Harvey Distinguished Chair in Advanced Cardiovascular Medicine, and a professor of medicine at Harvard Medical School. He is past-president of both the Heart Failure Society of America and the International Society of Heart and Lung Transplantation. 

Feature | Cardiovascular Business | April 15, 2019 | William W. Pinsky, M.D., FAAP, FACC, and Mandeep R. Mehra, MBBS, MSc , FRCP
As we strive to process today’s successive news cycles involving negative reports about immigration, it is easy for m
ACC Combines NCDR, Accreditation Into New Quality Summit
News | Cardiovascular Business | March 15, 2019
The American College of Cardiology’s first annual ACC Quality Summit, held March 13-15 in New Orleans, merges the NCDR...
Diagnostic and Interventional Cardiology Named 2019 Azbee Awards Finalist for Social Media
News | Cardiovascular Business | March 08, 2019 | Jeff Zagoudis, Associate Editor
Diagnostic and Interventional Cardiology (DAIC) was named a finalist in the Social Media Presence category for the 2019...
 FDA Commissioner Scott Gottlieb Announces Resignation
News | Cardiovascular Business | March 05, 2019 | Jeff Zagoudis, Associate Editor
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., resigned from his position March 5 after two...
Diagnostic and Interventional Cardiology Honored as Jesse H. Neal Awards Finalist

An example of the new transesophageal echo (TEE) visualization technology called TrueVue was shown at TCT 2018 for the first time. Philips’ new photo-realistic rendering is designed to offer a surgical view of cardiac structures to aid transcatheter procedural navigation.

News | Cardiovascular Business | February 25, 2019
Diagnostic and Interventional Cardiology has been recognized as a finalist in the Jesse H. Neal Awards for the third...
GE to Postpone Healthcare IPO Following Biopharmaceutical Business Sale
News | Cardiovascular Business | February 25, 2019 | Jeff Zagoudis, Associate Editor
GE Healthcare announced Feb. 25 the sale of its biopharmaceutical business to Danaher, and GE Chairman and CEO Larry...
Medical Bills Financially Burden Almost Half of Cardiovascular Disease Patients
News | Cardiovascular Business | February 11, 2019
Over 45 percent of adult atherosclerotic cardiovascular disease (ASCVD) patients suffer financial hardship related to...
Researchers raised the question whether an economic benefit should be assessed in FDA reviews. A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters.

A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters. Researchers raised the question whether an economic benefit should be assessed in FDA reviews. 

Feature | Cardiovascular Business | January 14, 2019 | Philip Jacobs, DPhil, Ilke Akpinar, M.D., Thanh Nguyen, M.D., Ph.D., Rupinder Sandhu, M.D., and Lars Thording Ph.D.
In an age when everything in medicine is now looked at though a cost vs. benefit analysis and U.S.
Overlay Init